Abbott Laboratories
Search results
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis . It developed Skyrizi ($7.8 billion in 2023 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases.
Our approach to innovation builds on strong science combined with the drive to find solutions where the need is the greatest. Our science. If we bring a new medicine to market, it can help patients worldwide, as opposed to the 20 or so patients we might see in clinic in one day.
Apr 18, 2022 · AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.
At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. We are committed to improving health care in markets where we operate. Passionate about our work. Responsible for our actions.
Finding Better Solutions to the Toughest Challenges. Research and innovation are the cornerstones of our business. We focus on discovering, developing and delivering drugs in therapeutic areas where we have proven expertise—and can make an impact. This includes Immunology, Oncology, Neuroscience and Virology.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues...
